← Back to Search

Antioxidant

Antioxidant Serum + Laser Treatment for Acne

N/A
Recruiting
Led By Edward Lain, MD, MBA
Research Sponsored by Austin Institute for Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Subjects currently using topically applied prescription medications on the face
Subjects with history of severe acne flares
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at day 98
Awards & highlights

Summary

"This trial is testing the effectiveness of an antioxidant serum combined with acne laser treatments to reduce oily skin in both male and female participants aged 18 to 65 with different skin types."

Who is the study for?
This trial is for healthy men and women aged 18-65 with mild to moderate acne who perceive their skin as oily. Participants must use approved birth control, have no health issues affecting the study, and agree to follow the study's rules including signing consent forms.Check my eligibility
What is being tested?
The study tests if a topical antioxidant serum can boost the effectiveness of AviClear laser treatments in reducing sebum production on one side of the face compared to laser treatment alone on the other side.See study design
What are the potential side effects?
Potential side effects may include skin irritation, redness, or sensitivity due to the antioxidant serum and temporary discomfort, swelling, or redness from laser procedures.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am using prescription skin creams on my face.
Select...
I have had severe acne outbreaks in the past.
Select...
I am not pregnant, nursing, or planning to become pregnant.
Select...
I haven't used AHA/BHA products in 2 weeks, Retin-A or similar in 8 weeks, or Accutane in a year.
Select...
I am being treated for cancer or have had facial skin cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at day 98
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at day 98 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Facial Acne Severity
Change in Subject Tolerability
Secondary outcome measures
Change in Skin Quality

Trial Design

2Treatment groups
Active Control
Group I: Topical Antioxidant Serum containing Silymarin CF (Right Face)Active Control2 Interventions
14 day application of topical antioxidant serum containing Silymarin CF Subjects will be given study drug and instructed to topically apply to the treatment area, the respectively randomized half of the face, once daily for 14 consecutive days.
Group II: Topical Antioxidant Serum containing Silymarin CF (Left Face)Active Control2 Interventions
14 day application of topical antioxidant serum containing Silymarin CF Subjects will be given study drug and instructed to topically apply to the treatment area, the respectively randomized half of the face, once daily for 14 consecutive days.

Find a Location

Who is running the clinical trial?

Austin Institute for Clinical ResearchLead Sponsor
5 Previous Clinical Trials
145 Total Patients Enrolled
SkinCeuticalsUNKNOWN
3 Previous Clinical Trials
89 Total Patients Enrolled
Edward Lain, MD, MBAPrincipal InvestigatorAustin Institute for Clinical Research
6 Previous Clinical Trials
176 Total Patients Enrolled
~7 spots leftby Apr 2025